









Markets
/
Stocks
/
nasdaq-aeon
/

Aeon Biopharma Inc

AEON

1.070USD

+0.060+5.94%

Close 12/19, 16:00（ET）Quotes delayed by 15 min

12.46MMarket Cap

0.37P/E TTM



Aeon Biopharma Inc

1.070

+0.060+5.94%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of Aeon Biopharma Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

Total equity

Cash, cash equivalents and short-term investments

1003.72%5.93M

145.18%8.44M

570.47%10.45M

-99.75%13.00K

-96.68%537.00K

32.23%3.44M

--1.56M

--5.16M

--16.18M

--2.60M

- Cash and cash equivalents

1003.72%5.93M

145.18%8.44M

570.47%10.45M

-99.75%13.00K

-96.68%537.00K

32.23%3.44M

--1.56M

--5.16M

--16.18M

--2.60M

Prepaid expenses

-19.03%1.49M

215.94%1.82M

99.47%1.88M

48.21%1.58M

149.86%1.83M

877.97%577.00K

--940.00K

--1.06M

--734.00K

--59.00K

Total current assets

212.61%7.41M

155.34%10.26M

393.23%12.32M

-74.45%1.59M

-85.98%2.37M

50.98%4.02M

--2.50M

--6.22M

--16.91M

--2.66M

Non-current assets

Net Fixed Assets

-19.39%1.29M

-18.68%1.37M

186.93%1.45M

156.40%1.52M

136.23%1.60M

120.68%1.69M

--505.00K

--594.00K

--679.00K

--764.00K

-Fixed Assets

-12.45%1.62M

-12.01%1.68M

147.86%1.73M

134.29%1.79M

124.00%1.85M

115.61%1.91M

--700.00K

--764.00K

--825.00K

--884.00K

-Accumulated depreciation

33.20%325.00K

39.09%306.00K

46.67%286.00K

57.06%267.00K

67.12%244.00K

83.33%220.00K

--195.00K

--170.00K

--146.00K

--120.00K

Other non-current assets

0.00%29.00K

-14.71%29.00K

--29.00K

--34.00K

Total non-current assets

-19.04%1.32M

-18.37%1.40M

176.78%1.48M

149.12%1.55M

130.65%1.63M

114.91%1.71M

--534.00K

--623.00K

--708.00K

--798.00K

Total assets

118.13%8.73M

103.38%11.66M

355.11%13.80M

-54.10%3.14M

-77.27%4.00M

65.72%5.73M

--3.03M

--6.84M

--17.62M

--3.46M

Liabilities

Current liabilities

-Other payables

-26.63%1.63M

-15.51%2.03M

-63.50%1.95M

29.21%2.46M

13.25%2.22M

--2.41M

--5.35M

--1.90M

--1.96M

----

Accrued expenses

2.14%3.83M

-39.34%2.95M

4.49%4.05M

-24.32%5.66M

-48.95%3.75M

-43.23%4.86M

--3.88M

--7.48M

--7.34M

--8.56M

Short-term debt and lease liabilities

----

--0.00

--73.43M

Other current liabilities

-26.63%1.63M

-15.51%2.03M

-63.50%1.95M

29.21%2.46M

13.25%2.22M

--2.41M

--5.35M

--1.90M

--1.96M

----

Total current liabilities

-23.29%8.23M

-12.47%9.13M

-45.85%8.64M

8.43%14.15M

-24.34%10.73M

-88.19%10.43M

--15.96M

--13.05M

--14.18M

--88.34M

Non-current liabilities

Long-term debt and lease liabilities

9.98%18.01M

11.27%16.19M

183.13%14.40M

--12.83M

31388.46%16.37M

-76.17%14.55M

--5.09M

--0.00

--52.00K

--61.06M

-Long-term debt

12.40%17.05M

14.16%15.17M

161.84%13.32M

--11.69M

--15.17M

-78.19%13.29M

--5.09M

--0.00

--60.93M

-Long-term lease liabilities

-20.51%957.00K

-19.18%1.02M

--1.08M

--1.15M

2215.38%1.20M

870.77%1.26M

----

--0.00

--52.00K

--130.00K

Derivatives liabilities

----

-100.00%0.00

-99.46%264.00K

--345.00K

--250.00K

--41.04M

--48.45M

----

Other non-current liabilities

-72.85%2.37M

-73.77%2.19M

-98.85%2.08M

-95.53%4.73M

-88.61%8.73M

--8.35M

--180.12M

--105.80M

--76.68M

--0.00

Total non-current liabilities

-19.67%20.38M

-20.93%18.39M

-91.11%16.48M

-88.04%17.56M

-79.74%25.37M

-61.92%23.25M

--185.46M

--146.84M

--125.18M

--61.06M

Total liabilities

-20.75%28.61M

-18.31%27.51M

-87.53%25.12M

-80.17%31.71M

-74.10%36.09M

-77.46%33.68M

--201.41M

--159.89M

--139.36M

--149.40M

Shareholders' equity

Common equity

3.04%413.81M

3.44%413.29M

4.56%411.18M

5.71%403.03M

10.90%401.59M

95.48%399.56M

--393.24M

--381.27M

--362.12M

--204.40M

Preferred equity

----

--124.13M

Retained earnings

-0.00%-433.68M

-0.38%-429.14M

28.59%-422.50M

8.87%-431.60M

-2.49%-433.68M

15.82%-427.51M

---591.62M

---473.60M

---423.15M

---507.86M

Capital reserves

3.04%413.80M

3.44%413.28M

4.56%411.17M

5.71%403.02M

10.90%401.58M

95.49%399.56M

--393.24M

--381.26M

--362.11M

--204.38M

Less: Treasury stock

----

--0.00

----

--23.00K

Non-controlling interests

----

--0.00

--19.59M

Total equity

38.07%-19.87M

43.28%-15.85M

94.29%-11.32M

81.33%-28.57M

73.64%-32.09M

80.85%-27.95M

---198.38M

---153.04M

---121.74M

---145.94M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

